Enbrel is a TNFα inhibitor FDA approved to treat arthritis and plaque psoriasis, with adverse interactions including headache, infection, rhinitis, and sepsis [11,37,38,39]. The gene discussed is TNF; the disease is psoriasis vulgaris.